| Social Space |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Networking > Mastermind Do's and Don'ts |
|
Social Space - Mastermind Do's and Don'ts
Several years ago I was invited to participate in a mastermind group. I had never been
involved in a mastermind group before, but I According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product had read about them in Napoleon Hill's book,
"Think and Grow Rich." So, I was eager to try the concept out. This particular group w ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s comprised of five women and the focus was real estate investing.
I met Kim, the woman who invited me to join the group, at a real lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. state investing seminar.
I was a relatively new investor at the time and thought this was an opportunity to learn
more about real here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe state investing, team up with other women who were investing, and jumpstart my real
estate investing business, which is a business I d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro run with my husband, in addition to my
marketing consulting and coaching business. In theory the group should have helped jumpstart ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y fledgling real estate investing business.
In reality it did not. We met weekly but we quickly realized that some of us were more se easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi rious
than others. Some of the members did not show up on a regular basis. Others seemed more
interested in spending our time toge nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically her socializing instead of focusing on the business
at hand. Kim, who had organized the group, tried very hard to set an agenda and and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ add value to the group.
But we quickly realized that if all the members were not 100% focused on the same goals,
it just was not g ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ing to work. The mastermind group disbanded after a few months. This experience taught me a few lessons. While there is definitely v ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a lue in masterminding with others, it's important to make sure you
are all focused on getting the same thing out of the relationship. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod And, that you are all seriously
committed. And most importantly, ground rules are imperative. My friend Lorrie Morgan-Ferrero of Re cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Hot Copy says her mastermind group members all must
agree to participate as if they had each spent $100,000 to be in the group. How tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen 's that for
making sure your members are serious? I haven't given up on masterminding. I've recently joined a new marketing master t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ind group comprised of other small business owners
and solo-professionals. We bounce ideas off each other. We share success stories ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust and challenges.
And we brainstorm - in fact, that is one of the primary benefits of a good mastermind group. The collective brainpow y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products r of all the members is definitely stronger than you'll achieve if
you're trying to run your business as a lone ranger. Plus, the n . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tworking and connections
that result from working with a team will help you grow your business much faster than you
can do working elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip solo. Just make sure you find a good group of people, who are all committed, and act as if they are paying to be a part of the group tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Many Woes of an Online Giant Direct Mail: Lifting Response With Lift Notes
|